Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

被引:13
作者
Ji, Kun [1 ]
Ma, Jianling [1 ]
Wang, Liangmin [1 ]
Li, Niuniu [1 ]
Dong, Shangjuan [1 ]
Shi, Liqing [1 ]
机构
[1] Beijing Univ Tradit Chinese Med, Dongfang Hosp, Dept Resp Med, Beijing 100078, Peoples R China
基金
中国国家自然科学基金;
关键词
EPIDEMIOLOGY; SURVIVAL; TRIAL;
D O I
10.1155/2020/1752387
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta-analysis. Methods. Randomized controlled trials (RCTs) related to TCM and IPF were searched on PubMed, EMBASE Cochrane Library, ClinicalTrials, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM) until December 2018. Standard mean difference (SMD) and 95% CI were calculated for the measurements related to lung function (FEV1/FVC, FVC%, FEV1%, TLC%, DLCO% or DLCO, and VC%) and other parameters (PO2, 6MWD, and SGRQ) when comparing TCM treatment to the control group. Relative risk (RR) and 95% CI of adverse events (AEs) were calculated to assess the safety of TCM. Results. A total of 40 RCTs comparing TCM to western medicine (WM) and involving 3194 IPF patients were eligible for the meta-analysis. The pooled results showed that TCM treatment improved significantly PO2 (SMD = 0.80, 95% CI 0.54 to 1.06, p < 0.001), FEV1% (SMD = 0.57, 95% CI 0.42 to 0.71, p < 0.001), DLCO% (SMD = 0.38, 95% CI 0.28 to 0.48, p < 0.001), 6MWD (SMD = 0.70, 95% CI 0.56 to 0.84, p < 0.001) and other measurements and reduced SGRQ scores (SMD = - 0.51, 95% CI - 0.70 to - 0.22, p < 0.001). Subgroup analysis of different study durations (3 months, >= 6 months) and comparison models (TCM vs. WM, TCM+ WM vs. WM or TCM vs. placebo) showed similar results. No significant difference of risk of AEs was observed between both groups (RR = 0.66, 95% CI: 0.27-1.60, p = 0.352). *ere was no obvious publication bias, and the pooled results were stable according to sensitivity analysis. Conclusion. To the best of our knowledge, the present study had the largest sample size. Our results indicated that TCM treatment may help provide benefit to the lung function, exercise capacity, and quality of life of IPF patients, alone or combined with WM, when compared to WM. More rigorous RCTs were needed in the future.
引用
收藏
页数:11
相关论文
共 50 条
[41]   Effect of anti-reflux therapy on pulmonary function in idiopathic pulmonary fibrosis: a systematic review and meta-analysis [J].
Yang, Mei ;
Dong, Jiajia ;
An, Jing ;
Liu, Lin ;
Chen, Lei .
JOURNAL OF THORACIC DISEASE, 2021, 13 (10) :5776-+
[42]   Single versus bilateral lung transplantation in idiopathic pulmonary fibrosis: A systematic review and meta-analysis [J].
Li, Diandian ;
Liu, Yi ;
Wang, Bo .
PLOS ONE, 2020, 15 (05)
[43]   Antacid Medication and Antireflux Surgery in Patients with Idiopathic Pulmonary Fibrosis A Systematic Review and Meta-Analysis [J].
Khor, Yet H. ;
Bissell, Brittany ;
Ghazipura, Marya ;
Herman, Derrick ;
Hon, Stephanie M. ;
Hossain, Tanzib ;
Kheir, Fayez ;
Knight, Shandra L. ;
Kreuter, Michael ;
Macrea, Madalina ;
Mammen, Manoj J. ;
Molina-Molina, Maria ;
Selman, Moises ;
Wijsenbeek, Marlies ;
Raghu, Ganesh ;
Wilson, Kevin C. .
ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (05) :833-844
[44]   Mortality-related risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analysis [J].
Sun, Xuege ;
Lei, Siyuan ;
Zhao, Hulei ;
Guo, Luhan ;
Wang, Yuan ;
Zhao, Hulei .
JOURNAL OF THORACIC DISEASE, 2024, 16 (12) :8338-8349
[45]   Prognostic factors for acute exacerbation of idiopathic pulmonary fibrosis: protocol for a systematic review and meta-analysis [J].
Kamiya, Hiroyuki ;
Panlaqui, Ogee Mer .
BMJ OPEN, 2019, 9 (05)
[46]   Higher body mass index was associated with a lower mortality of idiopathic pulmonary fibrosis: a meta-analysis [J].
Pan, Dengyun ;
Wang, Qi ;
Yan, Bingdi ;
Su, Xiaomin .
JOURNAL OF HEALTH POPULATION AND NUTRITION, 2024, 43 (01)
[47]   Meta-analysis of the synergistic effect of traditional Chinese medicine compounds combined with conventional Western medicine in the treatment of osteoporosis [J].
Jin, Huan ;
Huang, Cai ;
Zhang, Yan ;
Dong, Ying ;
Xiong, Qi ;
Wang, Di ;
He, Ziyi ;
Shen, Lin ;
Ma, Chen ;
Wang, Zixian ;
Zeng, Lingfeng ;
Shuai, Bo .
FRONTIERS IN ENDOCRINOLOGY, 2025, 16
[48]   Nintedanib - efficacy, safety and practical aspects of treatment for patients with idiopathic pulmonary fibrosis [J].
Martusewicz-Boros, Magdalena ;
Gorska, Katarzyna .
ADVANCES IN RESPIRATORY MEDICINE, 2020, 88 (06) :599-607
[49]   Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis [J].
Gulati, Swati ;
Luckhardt, Tracy R. .
DRUG HEALTHCARE AND PATIENT SAFETY, 2020, 12 :85-94
[50]   Shengmai Injection, a Traditional Chinese Patent Medicine, for Intradialytic Hypotension: A Systematic Review and Meta-Analysis [J].
Chen, Chao-yang ;
Lu, Ling-yan ;
Chen, Peng ;
Ji, Kang-ting ;
Lin, Jia-feng ;
Yang, Peng-lin ;
Tang, Ji-fei ;
Wang, Yan .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013